Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab.
Noel J, Jouinot A, Alexandre J, Ulmann G, Bretagne M, Castel-Ajgal Z, De Percin S, Vaquin-Villeminey C, Revel MP, Peyromaure M, Boudou-Rouquette P, Arrondeau J, Gataa I, Durand JP, Goldwasser F, Huillard O. Noel J, et al. Among authors: peyromaure m. Cancers (Basel). 2022 Jun 30;14(13):3214. doi: 10.3390/cancers14133214. Cancers (Basel). 2022. PMID: 35804986 Free PMC article.
Angiotensin System Inhibitors in Renal Cell Carcinoma--Letter.
Huillard O, Xylinas E, Peyromaure M, Alexandre J, Goldwasser F. Huillard O, et al. Among authors: peyromaure m. Clin Cancer Res. 2016 Jan 15;22(2):524. doi: 10.1158/1078-0432.CCR-15-2102. Clin Cancer Res. 2016. PMID: 26773163 No abstract available.
Pharmacokinetic/Pharmacodynamic Relationship of Enzalutamide and Its Active Metabolite N-Desmethyl Enzalutamide in Metastatic Castration-Resistant Prostate Cancer Patients.
Joulia ML, Carton E, Jouinot A, Allard M, Huillard O, Khoudour N, Peyromaure M, Zerbib M, Schoemann AT, Vidal M, Goldwasser F, Alexandre J, Blanchet B. Joulia ML, et al. Among authors: peyromaure m. Clin Genitourin Cancer. 2020 Apr;18(2):155-160. doi: 10.1016/j.clgc.2019.05.020. Epub 2019 Jun 13. Clin Genitourin Cancer. 2020. PMID: 31630979
Preexisting Autoantibodies and Immune Related Adverse Events in Metastatic Urothelial Carcinoma Patients Treated by Pembrolizumab.
Castel-Ajgal Z, Goulvestre C, Zaibet S, Arrondeau J, Bretagne M, Peyromaure M, Batteux F, Alexandre J, Goldwasser F, Huillard O. Castel-Ajgal Z, et al. Among authors: peyromaure m. Clin Genitourin Cancer. 2022 Oct;20(5):e362-e368. doi: 10.1016/j.clgc.2022.04.002. Epub 2022 Apr 21. Clin Genitourin Cancer. 2022. PMID: 35577731
Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee.
Masson-Lecomte A, Vaillant V, Roumiguié M, Lévy S, Pradère B, Peyromaure M, Duquesne I, De La Taille A, Lebâcle C, Panis A, Traxer O, Leon P, Hulin M, Xylinas E, Audenet F, Seisen T, Loriot Y, Allory Y, Rouprêt M, Neuzillet Y; French CCAFU Bladder Cancer Group. Masson-Lecomte A, et al. Among authors: peyromaure m. Cancers (Basel). 2022 Nov 6;14(21):5452. doi: 10.3390/cancers14215452. Cancers (Basel). 2022. PMID: 36358870 Free PMC article.
Chromophobe renal cell carcinoma: analysis of 61 cases.
Peyromaure M, Misrai V, Thiounn N, Vieillefond A, Zerbib M, Flam TA, Debré B. Peyromaure M, et al. Cancer. 2004 Apr 1;100(7):1406-10. doi: 10.1002/cncr.20128. Cancer. 2004. PMID: 15042674 Free article.
Tim-3 Expression on Tumor-Infiltrating PD-1+CD8+ T Cells Correlates with Poor Clinical Outcome in Renal Cell Carcinoma.
Granier C, Dariane C, Combe P, Verkarre V, Urien S, Badoual C, Roussel H, Mandavit M, Ravel P, Sibony M, Biard L, Radulescu C, Vinatier E, Benhamouda N, Peyromaure M, Oudard S, Méjean A, Timsit MO, Gey A, Tartour E. Granier C, et al. Among authors: peyromaure m. Cancer Res. 2017 Mar 1;77(5):1075-1082. doi: 10.1158/0008-5472.CAN-16-0274. Epub 2016 Nov 21. Cancer Res. 2017. PMID: 27872087
187 results